US SB5459 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on December 9 2024 - 25% progression
Action: 2024-12-09 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Status: Introduced on December 9 2024 - 25% progression
Action: 2024-12-09 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Summary
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Title
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Sponsors
| Sen. Marsha Blackburn [R-TN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-12-09 | Senate | Read twice and referred to the Committee on Finance. |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/5459/all-info |
